1. Home
  2. BEAM vs UTF Comparison

BEAM vs UTF Comparison

Compare BEAM & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • UTF
  • Stock Information
  • Founded
  • BEAM 2017
  • UTF 2004
  • Country
  • BEAM United States
  • UTF United States
  • Employees
  • BEAM N/A
  • UTF N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • UTF Finance Companies
  • Sector
  • BEAM Health Care
  • UTF Finance
  • Exchange
  • BEAM Nasdaq
  • UTF Nasdaq
  • Market Cap
  • BEAM 2.3B
  • UTF 2.5B
  • IPO Year
  • BEAM 2020
  • UTF N/A
  • Fundamental
  • Price
  • BEAM $30.43
  • UTF $24.65
  • Analyst Decision
  • BEAM Buy
  • UTF
  • Analyst Count
  • BEAM 10
  • UTF 0
  • Target Price
  • BEAM $48.75
  • UTF N/A
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • UTF 266.0K
  • Earning Date
  • BEAM 03-04-2025
  • UTF 01-01-0001
  • Dividend Yield
  • BEAM N/A
  • UTF 8.21%
  • EPS Growth
  • BEAM N/A
  • UTF N/A
  • EPS
  • BEAM N/A
  • UTF N/A
  • Revenue
  • BEAM $349,643,000.00
  • UTF N/A
  • Revenue This Year
  • BEAM N/A
  • UTF N/A
  • Revenue Next Year
  • BEAM $14.62
  • UTF N/A
  • P/E Ratio
  • BEAM N/A
  • UTF N/A
  • Revenue Growth
  • BEAM 328.73
  • UTF N/A
  • 52 Week Low
  • BEAM $20.84
  • UTF $18.15
  • 52 Week High
  • BEAM $49.50
  • UTF $24.49
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 57.12
  • UTF 58.81
  • Support Level
  • BEAM $25.35
  • UTF $24.36
  • Resistance Level
  • BEAM $35.25
  • UTF $24.60
  • Average True Range (ATR)
  • BEAM 2.10
  • UTF 0.26
  • MACD
  • BEAM 0.56
  • UTF 0.02
  • Stochastic Oscillator
  • BEAM 55.88
  • UTF 94.20

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

Share on Social Networks: